Table 2 Demographics
From: Tel-eVax: a genetic vaccine targeting telomerase for treatment of canine lymphoma
ID | Breed | Weight (kg) | Gender | Age (m) | Tumor type | Previous treatment | Number of boosters |
|---|---|---|---|---|---|---|---|
3732 | G. Schnauzer | 40.7 | MN | 84 | DLBCL | l-CHOP, bendamustine, epirubicin | None |
1301 | GR | 37.5 | FS | 84 | DLBCL | l-CHOP, mito/actinomycin, MOPP | None |
4603 | GR | 37 | M | 93 | DLBCL | l-CHOP | 5 |
5767 | GSD | 44.4 | M | 60 | DLBCL | l-CHOP, MOPP, GS-9219 | None |
5971 | Mix K9 | 37 | MN | 141 | DLBCL | l-CHOP | None |
6042 | Terrier Mix | 33.2 | MN | 45 | DLBCL | CHOP-MA | None |
6355 | GR | 36.7 | MN | 132 | DLBCL | l-CHOP | None |
6377 | Bassett | 22.6 | FS | 108 | DLBCL | l-CHOP | None |
6902 | GSD | 40 | MN | 75 | DLBCL, HSA | l-CHOP, leukeran | None |
7402 | Mix K9 | 26.7 | FS | 132 | DLBCL | l-CHOP | 4 |
7795 | Springer Spaniel | 16.3 | MN | 158 | DLBCL | l-CHOP | None |
138 | Golden Ret | 45.1 | FS | 52 | DLBCL | l-CHOP | None |
387 | Labradoodle | 34.7 | MN | 63 | DLBCL | l-CHOP | 3 |
457 | Pomeranian | 5.9 | FS | 49 | Stage V BLSA (bone marrow) | l-CHOP | None |
477 | Shihtzu | 6.5 | MN | 72 | DLBCL | l-CHOP | None |
492 | Havanese | 22.9 | FS | 87 | DLBCL | CHOP | 2 |
1108 | GR | 38.6 | FS | 39 | DLBCL | l-CHOP | None |